Active ingredient

Salicylic acid 2%

Purpose

Acne Treatment

Use

for the treatment of acne

Warnings

For external use only

When using this product

skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center right away

Directions

cleanse skin thoroughly before applying
cover the entire affected area with a thin layer one to two times daily, avoid eye area
because excessive drying of the skin may occur, start with one application daily, then gradually increase to two times daily if needed or as directed by a doctor
if bothersome dryness or peeling occurs, reduce application to once a day or every other day

Inactive Ingredients

alcohol denat.,hamamelis virginiana (witch hazel) water,acrylates/c10-30 alkyl acrylate crosspolymer,sucrose,yeast extract\faex\extrait de levure,laminaria saccharina extract,lactobacillus ferment,butylene glycol,water\aqua\eau,benzoic acid,phenoxyethanol,potassium sorbate <iln52924>

CLINIQUE
acne solutions
clinical

advanced clearing gel

2% SALICYLIC ACID
ACNE MEDICATION

0.68 FL.OZ.LIQ/20 ml

PDP

ACNE SOLUTIONS CLINICAL ADVANCED CLEARING GEL
salicylic acid gel

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:49527-221
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	20 mg in 1 mL

Ingredient Name	Strength
Inactive Ingredients
SUCROSE (UNII: C151H8M554)
BENZOIC ACID (UNII: 8SKN0B0MIM)
SACCHARINA LATISSIMA (UNII: 68CMP2MB55)
YEAST (UNII: 3NY3SM6B8U)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
DEHYDRATED ALCOHOL (UNII: 3K9958V90M)
HAMAMELIS VIRGINIANA TOP WATER (UNII: NT00Y05A2V)
ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (60000 MPA.S) (UNII: 8Z5ZAL5H3V)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
WATER (UNII: 059QF0KO0R)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:49527-221-01	1 in 1 CARTON	03/03/2025
1		20 mL in 1 BOTTLE; Type 0: Not a Combination Product
2	NDC:49527-221-02	1 in 1 CARTON	03/03/2025
2		10 mL in 1 TUBE; Type 0: Not a Combination Product
3	NDC:49527-221-03	1 in 1 CARTON	03/03/2025
3		3 mL in 1 TUBE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC Monograph Drug	M006	03/03/2025

Labeler - CLINIQUE LABORATORIES LLC (044475127)

Registrant - Estee Lauder Companies Inc. (790802086)

Name	Address	ID/FEI	Business Operations
Establishment
The Estee Lauder Inc		802599436	manufacture(49527-221)

Name	Address	ID/FEI	Business Operations
Establishment
Estee Lauder N.V.		370151326	manufacture(49527-221)

Name	Address	ID/FEI	Business Operations
Establishment
NORTHTEC LLC		943871157	pack(49527-221) , label(49527-221)

Name	Address	ID/FEI	Business Operations
Establishment
PALC		078364654	pack(49527-221) , label(49527-221)